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ABSTRACT
Circular RNAs (circRNAs) perform diverse functions,
including the regulation of transcription, transla-
tion, peptide synthesis, macromolecular sequestra-
tion and trafficking. Inverted Alu repeats capable of
forming RNA:RNA duplexes that bring splice sites
together for backsplicing are known to facilitate cir-
cRNA generation. However, higher limits of circRNAs
produced by a single Alu-rich gene are currently not
predictable due to limitations of amplification and
analyses. Here, using a tailored approach, we re-
port a surprising diversity of exon-containing circR-
NAs generated by the Alu-rich Survival Motor Neuron
(SMN) genes that code for SMN, an essential multi-
functional protein in humans. We show that expres-
sion of the vast repertoire of SMN circRNAs is univer-
sal. Several of the identified circRNAs harbor novel
exons derived from both intronic and intergenic se-
quences. A comparison with mouse Smn circRNAs
underscored a clear impact of primate-specific Alu
elements on shaping the overall repertoire of human
SMN circRNAs. We show the role of DHX9, an RNA
helicase, in splicing regulation of several SMN ex-
ons that are preferentially incorporated into circR-
NAs. Our results suggest self- and cross-regulation
of biogenesis of various SMN circRNAs. These find-
ings bring a novel perspective towards a better un-
derstanding of SMN gene function.
INTRODUCTION
Circular RNAs (circRNAs) are a widely expressed class of
non-colinear RNAs (NCRs) generated in a diverse set of
eukaryotic organisms, including animals, plants, yeasts and
protists (1–3). Due to their lack of 5′ and 3′ termini, cir-
cRNAs are extremely stable. They are suggested to carry
out diverse functions including sponging of microRNAs
(miRNAs), sequestration and trafficking of proteins, reg-
ulation of transcription and generation of short proteins
(4–6). The most common method of circRNA biogenesis
is through backsplicing, in which the 5′ splice site (5′ss) of
a downstream exon is paired with the 3′ss of an upstream
exon (1). Backsplicing can occur in both linear pre-mRNAs
and within lariat intermediates harboring skipped exons
(7,8). In the absence of backsplicing, lariat intermediates
can directly produce circRNAs by degradation of the lin-
ear 3′ sequence of the lariat (9). The latter mechanism is
predominantly used for producing intron-only-containing
circRNAs. There is also evidence to suggest that tissue-
specific factors independently regulate biogenesis of cir-
cRNAs (10–12). While recent transcriptome-wide analyses
of linear RNA-depleted samples reveal a surprising diver-
sity and abundance of circRNAs produced by the human
genome (13,14), findings also underscore several limitations
of the currently available algorithms in accurately mapping
unusual and novel splice site junctions used for the gener-
ation of circRNAs (15). Therefore, the current number of
circRNAs known to be generated by the human genome in
all probability represents an underestimate.
Backsplicing, similar to forward splicing, is likely regu-
lated by a complex combinatorial control in which both
cis-elements and transacting factors play important roles.
Based on the usage of the same 3′ss for the generation of
both linear and circRNAs in most cases, it has been sug-
gested that circRNAs are produced in competition with lin-
ear RNAs (16). One of the defining features of backsplic-
ing events appears to be the role of an RNA secondary
structure formed by inverted short repeats within intronic
sequences upstream and downstream of the 3′ and 5′ss.
Among the most common sources of such inverted repeats
are short interspersed nuclear elements (SINEs) including
primate-specific Alu elements that make up a large por-
tion (∼11%) of the human genome (17–19). Alu elements
are ∼300-bp bipartite motifs that have dramatically im-
pacted the evolution of the human genome through their
consequential effects on chromatin structure, transcription,
DNA repair and pre-mRNA splicing (20–28). Inverted Alu
repeats (IARs) promote circRNA generation due to their
ability to loop-out sequences by forming stable double-
stranded RNA structures (19,29–31). Consistently, deple-
tion of DHX9, an RNA helicase that specifically disrupts
the IAR-associated-double-stranded RNA structures, was
*To whom correspondence should be addressed. Tel: +1 515 294 8505; Fax: +1 515 294 2315; Email: singhr@iastate.edu
†The authors wish it to be known that, in their opinion, the first three authors should be regarded as Joint First Authors.
C© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which








niversity user on 08 February 2019
2 Nucleic Acids Research, 2019
shown to enhance the generation of a subset of circR-
NAs (32). Alu elements themselves harbor sequences re-
sembling splice sites and account for ∼5% of alternatively
spliced exons in humans (33–35). However, this number
could be even larger since linear transcripts carrying Alu
exons harboring premature termination codon escape de-
tection due to nonsense-mediated decay (27). Currently, it
is not known if Alu-derived exons have a higher represen-
tation in circRNAs than in linear transcripts. In addition
to promoting circRNA generation, IARs facilitate produc-
tion of trans-spliced RNAs (tsRNAs) in which exons from
two different transcripts of the same or different genes are
ligated together (36). There is also evidence to suggest that
IARs facilitate generation of trans-spliced circRNAs (ts-
circRNAs), albeit with lower frequency (36). As per current
estimate, circRNA levels within human cells vary from 2 to
4% of total mRNA and may even be higher in certain cell
types (15). However, there is no systematic study capturing
the higher limits of diversity of circRNAs and ts-circRNAs
generated by a single gene. According to the increasingly
accepted transcription-coupledmodel of splicing, intron re-
moval occurs during transcription and the rate of transcrip-
tion elongation by RNA polymerase II (pol II) affects the
outcome of splicing (37). It has been also suggested that
the secondary structure of pre-mRNA affects the rate of
pol II elongation and may even cause premature termina-
tion of transcription (38). Hence, it is expected that sec-
ondary structures associated with IARs regulate circRNA
generation through modulation of transcription elongation
and/or transcription termination.
Humans carry two nearly identical copies of the Survival
Motor Neuron genes: SMN1 and SMN2 (39). Both SMN
genes generally contain nine annotated exons (exons 1, 2A,
2B, 3, 4, 5, 6, 7 and 8), with exon 7 being the last coding
exon. Hence, exon 8, the final annotated exon, primarily
serves as the 3′ untranslated region. Rarely, a portion of
intron 6 derived from the left arm of an antisense AluY
element is exonized, creating an additional exon called 6B
(40). SMN1 codes for SMN, a multifunctional protein as-
sociated with RNA metabolism including small nuclear ri-
bonucleoprotein (snRNP) biogenesis, transcription, trans-
lation and RNA trafficking (41). SMN2 primarily codes for
a truncated protein, SMN7, due to predominant skipping
of SMN2 exon 7 (42–44). Low levels of SMN caused by
deletion or mutation of SMN1 leads to spinal muscular at-
rophy (SMA), one of the leading genetic diseases associated
with infantmortality (45). ConsideringSMN2 is universally
present in SMA patients, correction of SMN2 exon 7 splic-
ing is considered to be an attractive approach for the treat-
ment of SMA (46,47). Numerous cis-elements and trans-
acting factors have been implicated in regulation of SMN2
exon 7 splicing (48). Our discovery of intronic splicing si-
lencer N1 (ISS-N1) led to the development of an antisense
oligonucleotide (ASO)-based drug, Spinraza™ (nusinersen),
currently approved for the treatment of SMA (49–51). En-
gineered U1 snRNPs (eU1s) annealing to ISS-N1 or in its
vicinity also promote SMN2 exon 7 inclusion and could po-
tentially serve as a therapeutic alternative for the treatment
of the disease (52,53). ISS-N1 is a complex regulatory ele-
ment that harbors a cryptic 5′ss (Cr1) overlapping negative
cis-elements as well as an inhibitory RNA structure (51,53).
Activation of Cr1 by an eU1 extends the length of exon 7 by
23 nucleotides (nt) in SMN carrying pathogenic mutations
at the 3′ or 5′ss of exon 7 (53). In addition to Cr1, several
other cryptic splice sites have been reported within SMN
genes (53). However, it is not known if any of these sites are
also used to generate circRNAs.
The SMN genes are highly enriched in SINEs, especially
Alu elements that are likely to provide a multilayered con-
trol of SMN gene expression (Figure 1; 54).More than forty
Alu elements occupy ∼39% of the transcribed region of
SMN. Sequences located upstream and downstream of the
SMN transcribed region are also rich in Alu elements (Fig-
ure 1). Despite an exceptional abundance of Alu elements
within SMN, exon 6B is the only Alu-derived SMN exon
that has been reported thus far (40), supporting a notion
that there is strong evolutionary pressure against exoniza-
tion of intronicAlu elements (27). As of now, only twoSMN
circRNAs, one containing exons 2B-to-4 and the other con-
taining exons 5 and 6, have been reported in circBase repos-
itory but not yet experimentally validated (54,55). In addi-
tion, no trans-splicing event involving endogenous SMN se-
quences has yet been described. We attribute the low num-
ber of the currently reported NCRs (circRNAs, tsRNAs
and/or ts-circRNAs) of SMN to the known technical chal-
lenges associatedwith the amplification of the less abundant
NCRs combined with the serious limitations of the existing
mapping algorithms that fail to accurately predict NCRs
(15). However, given their unusually high SINE content, we
reason that the human SMN genes present an ideal system
to test the higher limits of diversity ofNCRs generated from
a single gene.
Here we employ a systematic approach to identify and
characterize SMN circRNAs expressed in various human
cell lines and tissues. Our results reveal near universal ex-
pression of an immense repertoire ofSMN circRNAs.Anal-
ysis of more than five hundred sequences that we cloned
confirmed that nearly all 5′ss of SMN participated in back-
splicing events. We show usage of several novel splice sites
as well as incorporation of three novel exons derived from
intronic sequences and four novel exons derived from the in-
tergenic sequences downstream of the final annotated exon
of SMN. We confirm incorporation of novel intergenic ex-
ons in both linear and circular transcripts of SMN. Our re-
sults also reveal unexpected trans-splicing events leading to
the insertion of foreign exonic sequences into several SMN
ts-circRNAs. A comparison of circRNAs generated by the
mouse and human genes suggest a clear impact of Alu ele-
ments on shaping the overall repertoire of human SMN cir-
cRNAs. Depletion of DHX9 supports the role of the IAR-
associated-double-stranded RNA structures in the genera-
tion of a subset of SMN circRNAs and implies competing
mechanisms by which specific SMN exons are incorporated
into linear vs. circular transcripts. Our results suggest self-
and cross-regulation of various circRNAs of SMN. Our
findings substantially expand the size of the SMN gene and
open the door for exploring additional regulatory mecha-
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Figure 1. SMN genes are rich in Alu repeats. A scale depiction of the SMN1 gene and surrounding intergenic sequences is shown. Exons are depicted by
colored shapes. Previously identified exons are outlined in black, novel exons identified in this study are outlined in red. Repeat sequences as identified by
Repeatmasker are depicted by colored arrows. Arrow direction indicates the orientation of the repeat sequence.
erned. Findings also bring a novel perspective towards a
better understanding of SMN gene function.
MATERIALS AND METHODS
Cell culture
All tissue culture media and reagents were purchased
from Life Technologies. HeLa, HEK-293 and SH-SY5Y
cells were obtained from American Type Culture Collec-
tion. Primary fibroblast cells from an SMA type I patient
(GM03813) were obtained from Coriell Cell Repositories.
Mouse NSC-34 cells were obtained from Dr. Neil Cash-
man (University of Toronto). HeLa, HEK-293 and mouse
NSC-34 cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine
serum (FBS). SH-SY5Y cells were cultured in a 1:1 mixture
of minimum essential medium (MEM) and F-12 nutrient
mixture supplemented with 10% FBS. GM03813 cells were
cultured in MEM supplemented with 15% FBS and 2 mM
GlutaMAX.
RNA isolation and RNase R treatment
Total RNA was isolated from cultured cells using TRIzol
reagent (Life Technologies) following themanufacturer’s in-
structions. RNA concentrationwas determined using a Bio-
mate 3 spectrophotometer (Thermo Scientific). Total RNA
was then treated with RQ1 RNase-free DNase (Promega)
according to the manufacturer’s instructions followed by
phenol:chloroform extraction, ethanol precipitation and re-
measurement of RNA concentration. Total RNA from hu-
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treatment was performed on 2 g of total RNA per 10 l
reaction using 0.5 l (10 U) of RNase R (abm) for 45 min
at 37◦C.Mock treatments in which the enzyme was omitted
were carried out in parallel in order to assess the efficiency
of digestion.
Reverse transcription and PCR (RT-PCR)
cDNA was generated from RNase R-treated or mock-
treated RNA using Superscript III reverse transcriptase
(RT) (Invitrogen) following themanufacturer’s instructions.
0.5 g RNA was used as template per 5 l RT reaction. To
prime the reactions, 0.5 pmol of exon-specific primers were
used (Supplementary Table 1). PCR was performed using
Taq DNA polymerase (New England Biolabs, NEB) fol-
lowing the manufacturer’s instructions. For circRNA am-
plification, primers followed a divergent amplification de-
sign, in which the 5′ primer was placed at the 3′ end of
the exon of interest and the 3′ primer was placed at the
5′ end. For linear RNA amplification, primers followed a
standard convergent design. Primer sequences are listed in
Supplementary Table S1. PCR products were separated on
native polyacrylamide gels and visualized by ethidium bro-
mide staining. To assess splicing of linear SMN, we em-
ployed a multi-exon-skipping detection assay (MESDA)
(56). For radioactive MESDA, the 3′ primer was labeled
with [ -32P]ATP (Perkin-Elmer) using T4 polynucleotide
kinase (NEB) and desalted using a Micro BioSpin P-30
spin column (Bio-Rad). After completion of electrophore-
sis, radioactive gels were dried, exposed to phosphorimager
screens, and scanned using a FujiFilm FLA-5100 system.
Quantitative Real-time RT-PCR (qPCR)
0.6 g of DNase-treated total RNA was reverse tran-
scribed in a 5 l reaction using SuperScript III RT. The
cDNA was further diluted 20-fold with RNase-free wa-
ter, and 3 l was then used in a 20 l of PCR reac-
tion using FastStart Universal SYBR Green Master mix
(ROX) (Roche). qPCR was performed using a Stratagene
Mx3005 qPCR system (Agilent Technologies). Primer se-
quences are listed in Supplementary Table S1. Data was
analyzed using Ct method with control set as the ref-
erence condition. For DHX9, DDX5 or DDX17 depleted
samples, cDNA was generated using oligo(dT)12–18 (Invit-
rogen), and the housekeeping gene, GAPDH, was used for
normalization. For DRB (5,6-dichlorobenzimidazole 1--
D-ribofuranoside) treated samples, cDNA was generated
using random primers (Promega), and 18S rRNA was used
for normalization.
Identification of circRNAs
Bands of interest corresponding to RT-PCR products were
excised from a 6% native polyacrylamide gel, and DNAwas
recovered by using ‘crush and soak’ method (56). A pGEM-
T Easy vector (Promega) was utilized to clone the recovered
DNA following the manufacturer’s instructions. After ini-
tial screening by blue/white colony selection on indicator
plates, colonies were subjected to a secondary screen using
colony PCR. Colonies with plasmids that carried inserts of
the expected size were propagated and plasmids were puri-
fied using the QIAprep Spin Miniprep Kit (Qiagen). Insert
identities were determined by Sanger sequencing. All novel
linear and circular RNAs sequences of SMN and Smn can
be accessed through the GenBank database at NCBI and
are also listed in Supplementary Tables S2 and S3, respec-
tively.
Polyadenylated mRNA enrichment
After isolation of total RNA, intact poly(A)+ RNAwas iso-
lated using a Magnetic mRNA Isolation kit (NEB) follow-
ing the manufacturer’s instructions. 40 g total RNA was
used as input, and after enrichment, poly(A)+ RNA was
eluted in 100 l of elution buffer. RNA was then concen-
trated by ethanol precipitation and resuspended in 10 l
of nuclease-free water. An estimated 0.1 g poly(A)+ RNA
(2.5 l) was used as template per 5 l RT reaction.
siRNA knockdown
To knock down the protein of interest, 1 × 106 HeLa
cells were reverse transfected in six-well plates with 50 nM
ON-TARGETplus siRNA (Dharmacon) or a non-targeting
pool of siRNA (Dharmacon) using Lipofectamine 2000
(Life Technologies) following the manufacturer’s instruc-
tions. Target sequences of siRNAs are listed in Supple-
mentary Table S4. Six hours after transfection, the cul-
ture medium was replaced with fresh medium. Twenty-
four hours after transfection, the cells were trypsinized and
transferred to 60 mm dishes in order to prevent overgrowth.
At 48 h post transfection, the entire process was repeated
for a total of 96 h total transfection time. To collect sam-
ples, cells were trypsinized, then transferred to two 1.5 ml
microfuge tubes. ∼2/3 of the cells were used for protein
extraction and western blotting, ∼1/3 for RNA isolation.
Cells were then spun down at 3500 × g for 1 min at 4◦C
to collect cell pellets. For total RNA isolation, supernatant
was removed and cells were lysed immediately in 1 ml of
TRIzol reagent and RNAwas prepared as described above.
For protein extraction, supernatant was removed and cells
were resuspended in 1 ml of ice-cold DPBS. The cells were
pelleted and the entire procedure was repeated twice for a
total of three washes in DPBS. After the final spin, the su-
pernatant was removed and cell pellets were frozen on dry
ice and stored at −80◦C.
DRB treatment in cells
DRB was obtained from Sigma. The required amount of
DRB was dissolved in DMSO (dimethyl sulfoxide) to pre-
pare 100 mM stock solution. HeLa cells were pre-plated at
a density of 0.5 × 106 cells per one well of a six-well plate
24 h prior to treatment. DRB was added with fresh growth
medium at a final concentration of 80 M; control samples
were treated with fresh medium alone or with an equiva-
lent amount of DMSO added. Eight hours after treatment
initiation, cells were lysed in TRIzol reagent for total RNA
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circRNA knockdown using gapmer ASOs
Modeled on a recent report (57), we designed RNase
H-competent gapmer ASOs that anneal to specific splice
junctions of circRNAs. All gapmers incorporated phos-
phorothioate modification throughout the body of the
ASO. Terminal 4, 5 or 6 residues on both ends carried
2′-O-methyl modified ribonucleotides and the middle 9 or
12 residues carried deoxyribonucleotides. Gapmers were
synthesized by Dharmacon, Inc. The sequences of the









sequences, the letter ‘m’ represents an O-methyl modifica-
tion at the second position of a sugar residue, the letter ‘d’
represents deoxyribonucleotides, and an asterisk represents
a phosphorothioate modification of the backbone. 1 × 106
HeLa cells were reverse transfected in six-well plates with
20 nM gapmer ASOs targeting specific circRNA junctions
or a non-targeting control gapmer using Lipofectamine
2000 following the manufacturer’s instructions. Six hours
after transfection, the culture media was replaced with fresh
media. Twenty-four hours after transfection, adherent cells
were re-transfected with gapmer at the same concentration.
At 24 h post second transfection, cells were collected for
RNA isolation using TRIzol reagent for a total of 48 h
transfection time.
Protein extraction and Western blotting
In order to extract proteins from cell pellets, cells were re-
suspended in 50l radioimmunoprecipitation assay (RIPA)
buffer (Boston Bioproducts) supplemented with HALT
protease inhibitor cocktail (Thermo Scientific). Cells were
lysed for 30 min on ice with occasional mixing. After-
wards, lysates were centrifuged at 12 000 × g for 15 min
at 4◦C and supernatant transferred to fresh pre-chilled 1.5
ml microcentrifuge tubes. Protein concentration was mea-
sured by Bio-Rad protein assay (Bio-Rad). An equal vol-
ume of 2× SDS loading buffer supplemented with 5% -
mercaptoethanol was added to each sample, followed by
boiling for 5 min to denature. Denatured samples were then
spun down at maximum speed for 5 min. Then, 20 g
of protein per sample was separated on 10% SDS-PAGE
gels and transferred to PVDF membranes using a Trans-
blot Turbo fast transfer system (Bio-Rad).Membranes were
blocked in 5% nonfat milk dissolved in Tris-buffered saline
containing 0.05% Tween-20 (TBST). Primary antibody in-
cubation was carried out at 4◦C overnight. Primary anti-
body dilutions were as follows: monoclonal mouse anti-
DHX9/NDH II 1:80 (Clone E-10, Santa Cruz sc-137183),
goat polyclonal anti-DDX5 1:800 (Abcam ab10261), rabbit
polyclonal anti-DDX17 1:400 (Santa Cruz sc-86408), rab-
bit polyclonal anti--actin 1:2000 (Sigma A2066), mouse
anti-GAPDH 1:4000 (Clone 6C5, Abcam ab8245), mouse
anti--tubulin 1:3000 (Sigma, T6199). After primary incu-
bation with primary antibodies, membranes were washed
thoroughly in TBST and incubated with secondary anti-
bodies conjugated to horseradish peroxidase for 1 h at room
temperature. Secondary antibodies and their dilutions were
as follows: goat anti-mouse 1:4000 (Jackson 115-035-003),
donkey anti-rabbit 1:2000 (GE Healthcare NA934), don-
key anti-goat 1:5000 (Santa Cruz sc-2020). After secondary
antibody incubations, membranes were washed thoroughly
and developed using SuperSignal West Femto Maximum
Sensitivity Substrate (Thermo Scientific) or Clarity ECL
Blotting Substrate (Bio-Rad). Bands were then visualized
using a UVP Biospectrum AC imaging system.
Computational analysis
To estimate the strength of the 5′ and 3′ss, Max-
EntScan scoring algorithm (http://genes.mit.edu/cgi-bin/
Xmaxentscan scoreseq.pl) was used, while HBond score
web interface was used to score 5′ss (http://www2.hhu.de/
rna/html/hbond score.php). To locate repetitive elements
within genomic sequences, RepeatMaskerWeb Server (http:
//www.repeatmasker.org/cgi-bin/WEBRepeatMasker) was
adopted. The mfold Web Server (http://unafold.rna.albany.
edu/?q=mfold/RNA-Folding-Form) was employed to pre-
dict RNA structures.
RESULTS
SMN generates a diverse set of circRNAs harboring the 5′-
terminal exons
In order to identify circRNAs generated by the 5′-terminal
exons of SMN, we prepared cDNA libraries using RNase
R-treated total RNA as template and reverse transcription
(RT) primers annealing to the first five internal exons (2A,
2B, 3, 4 and 5). We then performed PCR employing diver-
gent primers annealing to each of these exons. To capture
cell-specific differences in the repertoire of SMN circRNAs,
we conducted these experiments in four cell lines: HeLa,
human embryonic kidney-derived (HEK-293), SMA pa-
tient fibroblasts (GM03813) and neuronal SH-SY5Y.While
HeLa, HEK-293 and SH-SY5Y cells contain both SMN1
and SMN2, GM03813 cells carry only SMN2 (49,56). We
optimized PCR conditions for every primer combination
used in this study using total RNA from SH-SY5Y cells and
were able to visualize highly expressed circRNAs at 28 cy-
cles of amplification (Supplementary Figure S1B). In con-
trast, linear SMN transcripts were detectable after as few
as 22 cycles of amplification, suggesting that each individ-
ual circRNA makes up only a very small portion of total
RNA expressed from the SMN loci (Supplementary Fig-
ure S1A). However, due to the sheer number of distinct cir-
cRNAs that we observed in this study, we conclude that
total expression of circRNAs is non-negligible. Since our
goal was to capture the broad spectrum of circRNAs irre-
spective of their abundance, we performed 35 cycles of PCR
amplification. Exon-specific amplifications producedmulti-
ple bands for all tested exons. We confirmed the identity of
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in the relative abundance of specific circRNAs when am-
plified using divergent primers annealing to different exons.
This is not unexpected considering the differences in the
structural contexts of different exons in a given circRNA.
In addition, circRNAs are known to display different lev-
els of RNase R sensitivity that can introduce high variabil-
ity between replicates even if replicates are generated at the
same time (19,58). Therefore, we presume the presence of a
circRNA in any one replicate to be affirmative evidence of
their formation. However, we consider a circRNA to be a
major product only after validation by at least two indepen-
dent PCR amplifications using divergent primer pairs an-
nealing to two different exons. Unless stated otherwise, all
circRNAs reported here were generated employing canoni-
cal U2 type (GU/AG) splice sites.
circRNAs exhibit a high degree of diversity, including
a wide variety of circRNAs generated from a single gene
(13,14). Even so, the sheer number of unique circRNAs gen-
erated by SMN was surprising. We classified SMN circR-
NAs into four major types based on the nature of the incor-
porated exons (Figure 2A). Type 1 circRNAs were made us-
ing exclusively the early transcribed (5′-terminal) SMN re-
gion spanning from exon 1 to exon 4. Among the type 1 cir-
cRNAs, we identified three novel exons derived from intron
1. We named them I1(NE1-98), I1(NE2-79) and I1(NE3-
33) (Figures 1 and 2, Supplementary Figure S2).We consid-
ered exons 5, 6, 6B and 7 as middle exons. Type 2 circRNAs
were made using at least one middle exon with or without
early exons.We considered exon 8 as well as downstream in-
tergenic exons as 3′-terminal exons. Type 3 circRNAs were
made using at least one 3′-terminal exon with or without
early and middle exons. Exons 9, 10, 11 and 12 are novel
exons that are generated from intergenic sequences down-
stream of exon 8 and are being reported for the first time
in this study (Figures 1 and 3, Supplementary Figure S3).
All novel exons, including those generated from intron 1 as
well as intergenic exons reported in this study use canonical
U2 type (GU/AG) splice sites. Type 4 circRNAs of SMN
harbored at least one exon from a different Alu-rich gene.
For the ease of explanation, we adopted a simple nomen-
clature in which ‘C’ stands for circRNA and numbers in the
ascending order represent the exon number of SMN. Num-
ber following an ‘I’ represents the intron number. The first
and the last numbers represent exons and/or introns that
provide the 3′ and the 5′ss, respectively. Use of ‘tr’ after the
number represents a truncated exon due to usage of a novel
3′ss within that exon. For novel 3′ss that were used in ma-
jor products, we named the truncated form with a number,
e.g. 9tr1. For less commonly used novel 3′ss, we put the new
exon size in parentheses after the ‘tr’, e.g. 6tr(61). A capi-
tal letter after the number represents usage of a novel 5′ss
within that exon, if that 5′ss was used in any major product.
For less commonly used novel 5′ss, we added the new exon
size in parentheses after the exon number. ‘cr’ after exon
name indicates intronic sequence included downstream of
5′ss, while ‘cp’ after exon name indicates intronic sequence
included upstream of the 3′ss. For products without canon-
ical splice sites, we adopted a simplified naming system. In
these cases, instead of ‘C’, we name each product with ‘T’
followed by the type number, followed by a letter designa-
tion. The full exon content and splice site locations of each
noncanonical circRNA candidate are given in Supplemen-
tary Table S5 and Supplementary Figure S9.
Our results revealed inclusion of early exons into 28 cir-
cRNAs, 16 of which belonged to type 1 (Figure 2A, Sup-
plementary Figure S4, Supplementary Table S3). We iden-
tified 9, 1 and 2 circRNAs belonging to types 2, 3 and 4,
respectively. Out of 28 circRNAs, 12 circRNAs shared the
3′ss of exon 2A in combination with different 5′ss. Detec-
tion of C2A, C2B, C3 and C4 in one or more cell lines con-
firmed single exon circularization for the first four internal
exons including the 72-nt long exon 2A, which is one of the
shortest exons of SMN. However, we did not detect single
exon circularization for the 96-nt long exon 5. Out of four
two-exon circRNAs we observed, C3-4 was the most abun-
dantly expressed in all cell types we examined (Figure 2B).
C3-4 was also one of the most abundant type 1 circRNAs,
suggesting that backsplicing of the 5′ss of exon 4 with the
3′ss of exon 3 is a frequent event. Interestingly, the predicted
secondary structure of intron 4 revealed very strong internal
stems stretching over a∼900-nt region (Supplementary Fig-
ure S5). It is likely that this structure facilitates backsplic-
ing. Out of five three-exon circRNAs we observed, C2B-3-
4 was the most abundantly expressed. The relative expres-
sion of C2B-3-4 was similar to that we observed for C3-4
(Figure 2B, lanes 9–16), suggesting that the 5′ss of exon 4
backspliced with the 3′ss of exons 2B and 3 with similar ef-
ficiency. The predicted secondary structure of a transcript in
which introns 2B and 3 have been removed revealed internal
stems formed between complementary sequences in intron
2A and exon 4 (Supplementary Figure S6). This structure
brings the 5′ss of exon 4 in close proximity to the 3′ss of ex-
ons 2B and likely facilitates backsplicing, leading to the gen-
eration of C2B-3-4. Between two circRNAs with four exons
we captured, C2A-2B-3-4 showed high expression, particu-
larly when amplified using divergent primers annealing to
exon 2A (Figure 2B). Interestingly, the 3′-end of intron 1
seemed to base pair extensively with exon 4 when the in-
tervening introns have been removed (Supplementary Fig-
ure S7). This arrangement brings the 5′ss of exon 4 closer
to the 3′ss of exon 2A, facilitating generation of C2A-2B-
3-4. However, levels of C2A-2B-3-4 appeared substantially
lower when amplified using divergent primers annealing to
exons 2B and 3. This could be due to poor annealing of RT
primer to exons 2B and 3 owing to rigid RNA structures.
We also detected two circRNAs with five exons and one cir-
cRNA with six exons (Figure 2A). However, these circR-
NAs were expressed at low levels in all cell types we tested
(Figure 2B).
Currently it is not known if the Alu-rich intron 1, the
largest intron of SMN, harbors a cryptic exon. In this study,
we identified four type 1 circRNAs encompassing cryp-
tic exons from intron 1 (Figures 1 and 2, Supplementary
Figures S2 and S4). One of these exons, I1(NE3-33), was
found in two circRNAs, suggesting its frequent usage. Ad-
ditional two type 1 circRNAs were generated using a novel
3′ss within exon 1 (Figure 2, Supplementary Figure S4). We
identified two circRNAs harboring a truncated exon 3 (Fig-
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Figure 2. Early exons of SMN are involved in formation of a wide variety of circRNAs. (A) Top panel: A genomic overview of the SMN gene layout is
shown. Exons are depicted as colored shapes, and introns are shown as lines/broken lines. Exon sizes are indicated by numbers in black below exons and
intron sizes are indicated by numbers in gray above introns. A novel 5′ss in exon 8 is marked with a black arrow. Colored arrows represent backsplicing
events, their thickness corresponds to the estimated prevalence of each event. Lower panels: An overview of all identified circRNAs that are produced by
canonical backsplicing events. Type 1 circRNAs are produced only by exons 1 through 4; type 2 circRNAs include some early exons and some late exons;
type 3 circRNAs include all circRNAs that contain exon 8A and/or downstream sequences. Type 4 circRNAs are produced by trans-splicing events and
include non-SMN sequences. The most abundant circRNAs are boxed in red. (B) Ethidium bromide stained gels of divergent RT-PCR products. Exons
to which divergent primers anneal are given at the top of each gel. Cell types used are indicated above each lane. Band identities marked on the right
side of each gel were determined by cloning and sequencing. Abbreviations are as follows: He, HeLa; Hk, HEK-293; GM, GM38013; SH, SH-SY5Y.
Nomenclature of circRNAs is as follows: ‘C’ followed by all exons in the mature circRNA. ‘I’ indicates exonized intronic sequence. ‘tr’ after the exon
number indicates that the exon is 5′ truncated, numbers in parentheses indicate sizes of novel or truncated exons. ‘(2X)’ indicates that the PCR product is
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Figure 3. Late exons of SMN are involved in formation of a wide variety of circRNAs. (A) Top panel: A genomic overview of the 3′ portion of the SMN
gene layout is shown. Lower panels: An overview of all identified circRNAs that are produced by canonical backsplicing events. Labeling and color coding
are the same as in Figure 2. (B) Ethidium bromide stained gels of divergent RT-PCR products. Labeling is the same as in Figure 2.
2 circRNA a novel 5′ss within exon 6 was used to back-
splice to exon 2A. C5-6-7-8A-9tr1, a type 3 circRNA, con-
tained a truncated exon 8 due to usage of a cryptic 5′ss
(GUAACU) at the 142nd position of this exon (Figure 2,
Supplementary Figure S9). We call this truncated exon 8
as exon 8A. C5-6-7-8A-9tr1 also incorporated exon 9tr1, a
truncated version of the novel exon 9 downstream of exon 8
(described later).We observed several type 1 circRNAswith
truncated exons 1, 2A, 2B, 3 and 4 (Supplementary Figure
S9). Other surprising findings were the identification of two
type 4 circRNAs generated by trans-splicing with sequences
from SERF1 andERBIN, respectively (Supplementary Fig-
ures S4 and S10). Both of these type 4 circRNAs used the
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Inclusion of novel intergenic exons expands the diversity of
SMN circRNAs
To identify circRNAs produced by the 3′-terminal exons of
SMN, we generated cDNAs using RNase R-treated RNAs
and RT primers annealing to exons 6, 6B, 7 and 8. We then
performed PCR employing divergent primers annealing to
these exons. Here again, we conducted these experiments in
four cell lines to capture the broad spectrum of circRNAs
generated in a cell-specific manner. Our results revealed 28
circRNAs harboring the 3′-terminal exons, 22 of which be-
longed to the type 3 category (Figure 3, Supplementary Ta-
ble S3). The remaining six circRNAs belonged to the type
2 category. Surprisingly, 15 circRNAs incorporated one or
two of four novel exons derived from intergenic sequences
downstream of exon 8. We named these exons as 9, 10, 11
and 12. Out of four intergenic exons, only exon 9 was de-
rived from an Alu element (Figure 1, Supplementary Fig-
ure S3). Hence, exon 9 becomes the second SMN exon after
exon 6B to be derived from an Alu element. In contrast to
exon 6B that maps to the left arm of the antisense sequence
of an Alu element, exon 9 maps to the right arm of the an-
tisense sequence of an Alu element (Figure 1). Exons 10
and 11 are derived fromDNAandLTR repeats, respectively
(Figure 1, Supplementary Figure S3). In several instances,
we observed circRNAs incorporating a truncated version
of exon 9 (9tr1) due to usage of a cryptic 3′ss located 4-nt
downstream of the 3′ss of exon 9. Interestingly, we recorded
more circRNAs with exon 9tr1 than with exon 9, suggesting
that the 3′ss of exon 9tr1 is stronger than the 3′ss of exon 9.
This matches the results of splice sites strength scoring, ac-
cording to which the 3′ss of exon 9tr1 is stronger than the
3′ss of exon 9 (Supplementary Table S6).We captured 9, 7, 3
and 1 circRNAs harboring exons 9/9tr1, 10, 11 and 12, re-
spectively, suggesting that early intergenic exons were more
frequently incorporated into circRNAs than later intergenic
exons. It is likely due to high probability of transcription
termination as RNA pol II moves into the intergenic re-
gion. Transcription of the intergenic region until exon 12
did not necessarily guarantee inclusion of all preceding in-
tergenic exons. For instance, C7-8A-11-12 that harbored ex-
ons 11 and 12 lacked intergenic exons 9 and 10. Also, we
did not capture any circRNA incorporating both exons 10
and 11, suggesting that these two intergenic exons are in-
cluded in a mutually exclusive manner. Notably, we did not
capture any circRNA harboring all four intergenic exons.
We observed two circRNAs that used cryptic 5′ss within in-
tron 7 (Figure 3, Supplementary Figure S9). Interestingly,
one of these cryptic 5′ss (GUCUGC) is located 4-nt down-
stream of the natural 5′ss of exon 7. This cryptic site over-
laps an inhibitory RNA structure as well as an 8-nucleotide
GC-richmotif (CUGCCAGC), sequestration of which pro-
motes SMN2 exon 7 inclusion (59–61). The other cryptic
5′ss used was Cr1, located 23-nt downstream of the natu-
ral 5′ss of exon 7. Cr1 is located upstream of the previously
reported TIA1 binding site and shows the highest potential
to be activated by an eU1 when the native 5′ss of exon 7 is
mutated (53,62). While most type 3 circRNAs incorporated
142-nt long exon 8A, we also observed circRNAs with var-
ied lengths of exon 8. Of these, only two circRNAs utilized
canonical U2 type (GU/AG) 5′ss located at 20- and 25-nt
downstream of the 5′ss of exon 8A. Other extremely low
abundant circRNAs appeared to use unusual 5′ss within
exon 8 (Supplementary Figure S9). However, manifestation
of these products could be an artefacts of the background
amplification.
We observed six circRNAs harboring exon 6B (Figure
3A). Four of these circRNAs also contained exons 6 and
7. Generation of these circRNAs confirmed that both the
5′ and 3′ss of exon 6B are used for circularization. Exons
6, 7 and 8 provided the 3′ss for the generation of 16, 4 and
2 type 3 circRNAs, respectively. The 3′ss of exons 4 or ear-
lier exons were not used for the generation of type 3 circR-
NAs. Overall, our experimental approach of employment
of divergent primers annealing to exons 6, 6B, 7 and 8A
cross validated the generation of various circRNAs. In par-
ticular, our results confirmed C6-7-8A as the most abun-
dant type 3 circRNA. Interestingly, computational folding
of the region spanning from intron 5 to exon 8 revealed a
predicted secondary structure that brings the 5′ss of exon
8A in close proximity of 3′ss of exon 6 when all of the in-
tervening introns are removed (Supplementary Figure S11).
Such a structural arrangement is likely conducive for the
generation of C6-7-8A. Analysis of 10 clones from HeLa
cells confirmed that both SMN1 and SMN2 generate C6-
7-8A with equal frequency. Except for exon 10-containing
circRNAs that were preferentially expressed from SMN1,
all other type 3 circRNAs we analyzed were generated from
both SMN1 and SMN2 (not shown). We observed five
bands bearing a variety of different circRNAs of similar
sizes, which we named as Group (Grp) 1–5 (Figure 3B). In
GM03813 cells, Grp 1 and Grp 3, which include a mixture
of exon 6B- and exon 10-containing circRNAs, were present
at noticeably lower levels.
While PCR amplification of the RNase R-treated sam-
ples employing divergent primers is the most commonly
accepted practice for the detection of circRNAs (15,63),
this approach is not foolproof due to artefacts associated
with the reverse transcription and PCR amplification steps.
Hence, we used RNase protection assays (RPAs) to inde-
pendently validate the nature of the backsplicing events
used to generate the most abundant circRNAs of SMN. We
chose RPA because of its high precision and increased sen-
sitivity compared to northern blotting (64,65). In an initial
survey of all major backsplice junctions as well as linear
SMN, we were able to identify strong signal using probes
complementary to the exons 2A-2B junction (identifying
linear SMN), as well as the backsplicing junctions between
exon 4 and exons 2A, 2B and 3, which recognize the three
most abundant type 1 circRNAs, C2A-2B-3-4, C2B-3-4 and
C3-4 (Supplementary Figure S12A, lanes 1–12). We also
identified weak signal using a probe complementary to the
backsplicing junction between exon 6 and exon 5, detect-
ing C5-6 (Supplementary Figure S12A, lanes 13–15). We
did not observe any signal from RPA using probes comple-
mentary to any of the type 3 circRNA backsplicing junc-
tions, suggesting their extremely low abundance (Supple-
mentary Figure S12A, lanes 16–24). Also, identification of
C6-7-8A was complicated by the presence of a nonspecific
band of the similar size (Supplementary Figure S12A, lanes
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tion of a circRNA can in principle also favor the genera-
tion of a trans-backspliced linear RNA involving the simi-
lar splice site pairing (36). Supporting the occurrence of the
trans-backsplicing events, RNase R-treated samples consis-
tently showed reduction in the intensity of the bands ampli-
fied using divergent primers (not shown). However, avail-
able methods do not reliably provide a quantitative estimate
of the backsplicing and trans-backsplicing events involv-
ing specific splice site pairings. To confirm the backsplicing
junctions in the three most abundantly expressed circRNAs
(C2A-2B-3-4, C2B-3-4 and C3-4), we performed RPAs in
RNase R-treated samples.We expected low signal in RNase
R-treated samples due to several reasons, including removal
of the trans-backspliced linear transcripts, nicking of cir-
cRNAs during RNA isolation and the presence of the con-
taminating RNases in the commercially available RNase R
preparation. Indeed, the residual signal after RNase R di-
gestion was greatly reduced compared to the mock-treated
samples. However, the signal for each of the backsplicing
junctions was greater than that for the linear SMN (Sup-
plementary Figure S12B), confirming the presence of the
backsplicing junctions leading to the generation of the all
three abundantly expressed SMN circRNAs. In addition,
the probe used for detection of linear SMN can also anneal
to C2A-2B-3-4, meaning that the amount of residual linear
RNA left after RNase R treatment is likely to be overesti-
mated.
Novel intergenic exons are incorporated into linear tran-
scripts of SMN
To validate that intergenic exons are incorporated into the
linear polyadenylated transcripts of SMN, we conducted a
series of experiments.We first enriched polyadenylated tran-
scripts from total RNA of HeLa cells using oligo-dT beads
and then generated cDNA using an oligo(dT)12–18 primer.
As a control, we performed a parallel experiment using
RNase R-treated sample. We subsequently performed PCR
using forward and reverse primers annealing to exons 6 and
12, respectively (Figure 4A). We determined the identities
of the amplified products by sequencing. Confirming incor-
poration of intergenic sequences in the linear transcripts,
we observed two equally intense SMN-specific bands in the
RNase R-untreated sample (Figure 4B). One of these bands
was generated by skipping of exon 10 of SMN1, whereas
the other band was generated by skipping of exons 9 and 10
of SMN1. To further confirm that exon 10 is also included
into the linear transcripts of SMN, we repeated the above
experiment using forward and reverse PCR primers anneal-
ing to exons 6 and 10, respectively. Here again, we observed
two equally intense bands in the RNaseR-untreated sample
(Figure 4C). One of these bands was generated by inclusion
of intergenic exon 9tr1 of SMN1, whereas the other band
was generated by skipping of exon 9/9tr1 of SMN1. Al-
though each of the sequences derived from linear transcripts
that we analyzed came from SMN1, we originally observed
circRNAs containing exons 11 and 12 in GM03813 cells,
which only contain SMN2. Thus, we conclude that both
SMN1 and SMN2 are capable of utilizing these exons. Our
results confirmed incorporation of all intergenic exons of
SMN into linear transcripts.
SMN circRNAs are universally expressed in human tissues
To determine the expression of SMN circRNAs in vivo, we
examined 10 human tissues including brain, spinal cord,
heart, skeletal muscle, smooth muscle, liver, kidney, lung,
uterus and testis. We prepared cDNAs using RNase R-
treated RNAs as template and RT primers annealing to ex-
ons 2A, 2B, 3, 4, 5 and 6. We amplified circRNAs by PCR
employing divergent primers annealing to the above exons.
Our approach was designed to capture the entire spectrum
of circRNAs. Consistent with the results observed with the
cultured cells, C2B-3-4 and C3-4 were the most abundant
type 1 circRNAs generated in all tissues examined (Figure
5B, lanes 21–40). Similar to the results obtained with the
cultured cells, C6-7-8A was the most abundant type 3 cir-
cRNA generated in all tissues examined (Figure 5B, lanes
51–60). These results validated the universal usage of the
novel 5′ss within exon 8 and incorporation of the truncated
exon 8A into circRNAs. Overall, our findings confirmed
that C2B-3-4, C3-4 and C6-7-8A are universally expressed
and constitute the most abundant circRNAs generated by
SMN. Our results also confirmed expression of several low
abundance circRNAs including those generated using novel
cryptic 3′ss within intron 1 and exon 1 (Figure 5B). Similar
to the observations we made using cultured cells, we cap-
tured differences in the expression of a handful of circR-
NAs when amplified using RT/PCR primers annealing to
different exons. For instance, C5-6, a type 2 circRNA, was
expressed>5-fold higher than C4-5-6 in all tissues when ex-
amined using exon 5-specific RT/PCR primers. However,
the expression of C5-6 was comparable to that of C4-5-
6 when examined using exon 6-specific RT/PCR primers.
Here again, we attribute these differences to the different
structural contexts of a given exon in different circRNAs.
We captured tissue-specific differences in the expression of
various low abundance SMN circRNAs. For instance, we
observed enhanced expression of C4 in testis compared to
all other tissues. Interestingly, C4 appeared to be absent in
kidney. C2A-2B-3-4 showed high expression in testis based
on exon 2B- and exon 4-specific amplification strategies.
However, similarly to cultured cells, in human tissues C2A-
2B-3-4 was poorly amplified using exon 3-specific primers.
Similar to the results obtained using cultured cells in
which we observed cell-type specific amplification of Grp1
circRNAs (Figure 3), we observed poor amplification of the
Grp1 population in brain, spinal cord, skeletal muscle, liver,
kidney and lung (Figure 5B). However, the Grp1 circRNAs
were amplified better in heart, smooth muscle, uterus and
testis (Figure 5B). While these results confirmed inclusion
of the intergenic exons into SMN circRNAs, they also sug-
gested tissue-specific regulation of transcription of the in-
tergenic region. Similar to the results we observed with the
cultured cells (Figure 3), the Grp2 circRNAs were univer-
sity expressed in all ten tissues examined (Figure 5B).
Mouse Smn generates a distinct set of circRNAs
Rodent specific SINEs including inverted B1 elements have
been implicated in the promotion of circRNA formation
(32). Unlike the high abundance of primate-specific SINEs
present within human SMN, the occurrence of SINEs
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Figure 4. Linear SMN transcripts showing inclusion of novel exons 9, 10, 11 and 12. (A) An overview of the 3′ portion of the SMN pre-mRNA. Splicing
events are indicated by dotted lines. Exons are depicted as colored shapes, and introns are shown as lines/broken lines. Exon sizes are indicated by numbers
in black below exons and intron sizes are indicated by numbers in gray above introns. Names, assigned numbers and the locations of primers used to amplify
linear SMN transcripts are presented. ‘’ indicates SMN transcripts with skipped exon(s). (B, C) Detection of novel exons 9, 10, 11 and 12 without (−)
and with (+) RNase R treatment. Primers used are shown at the top of each gel. After purification of total RNA, we isolated intact poly(A)+ RNA using
magnetic beads and generated cDNA employing oligo(dT)12–18 primer. The identities of bands marked on the left of each gel were determined by cloning
and sequencing. Abbreviations: NS, non-specific.
determine whether mouse Smn generates circRNAs, we
used mouse motor-neuron-like NSC-34 cells. We prepared
cDNA libraries using RNase R-treated RNA as a template
and RT primers annealing to all internal exons as well as
exon 8, which is the last annotated exon.We then performed
PCR employing divergent primers annealing to all internal
exons as well as in exon 8. For clarity, we adopted a nomen-
clature in which we used prefix ‘m’ for mouse circRNAs.
As expected, we captured a less diverse repertoire of mouse
Smn circRNAs as compared to those produced by human
SMN. For example, compared to 16 type 1 circRNAs gen-
erated by human SMN, we observed only five type 1 cir-
cRNAs generated by mouse Smn utilizing canonical splice
sites (Figure 6).We observed an additional three candidate
circRNAs, mT1A, mT1D and mT1E, that appeared to use
unusual splice sites for backsplicing (Figure 6, Supplemen-
tary Figure S14). It is likely that RT slippage led to the dele-
tion of the backsplicing junction of these three circRNAs.
Interestingly, five type 1 circRNAs (mC2A-2B, mC2A-2B-
4, mC2A-2B-3-4, mC2B-3 and mC4) were similar to those
generated by human SMN. Out of these circRNAs, mC2A-
2B-3-4 was the most abundantly expressed (Figure 6). Sim-
ilar to human SMN, the predicted secondary structure in-
volved RNA-RNA interaction between intron 1 and exon 4
(Supplementary Figure S15). Such an arrangement is likely
to facilitate backsplicing between the 5′ ss of exon 4 and the
3′ ss of exon 2A. Unlike human SMN that produces C2B-3-
4 and C3-4 as the major circRNAs, we did not detect analo-
gous circRNAs generated by mouse Smn. We attribute this
difference to the complete absence of SINEs within introns
2A and 2B of mouse Smn (Supplementary Figure S13).
We detected twelve type 2 circRNAs generated by mouse
Smn (Figure 6). Only five of these circRNAs (mC2A-2B-
3-4-5-6, mC2A-2B-3-4-5, mC5-6, mC5-6-7 and mC6) were
similar to those generated by human SMN. Interestingly,
three circRNAs incorporated a novel exon derived from
an antisense strand of an ID4 element located within in-
tron 6 (Supplementary Figure S16). We term this 108-nt
long novel exon as exon 6B, although it should be noted
that it shares no resemblance to that of human SMN exon
6B (Supplementary Figure S16). We confirmed that mouse
Smn exon 6B is also incorporated into linear transcripts
(Supplementary Figure S16). In contrast to human SMN
that generated only two circRNAs (C5-6-7 and C6B-7) us-
ing the 5′ss of exon 7, about half of the type 2 circRNAs
of mouse Smn were generated using the 5′ss of exon 7. We
detected three type 3 circRNAs (mC2A-2B-3-4-5-6-7-8A,
mC5-6-7-8A and mC7-8A) that incorporated a truncated
exon 8 that we term exon 8A. Inclusion of exon 8Awas facil-
itated by activation of a novel 5′ss (GUGCGU) at the 192nd
position of exon 8. Of note, exon 8A of mouse Smn bears
no resemblance to exon 8 of human SMN. Also, the score
of the 5′ss of mouse Smn exon 8A was lower than the hu-
man SMN exon 8A (Supplementary Tables S6 and S7). Un-
like in humans, where the longest circRNAs incorporated 6
exons (C2A-2B-3-4-5-6, C5-6-6B-7-8A-9tr1 and C6-6B-7-
8A-9tr1-10), in mouse NSC-34 cells we identified circRNA
that contained eight exons (mC2A-2B-3-4-5-6-7-8A): all in-
ternal ones plus exon 8A (Figure 6G). Importantly, mouse
Smn did not produce circRNAs incorporating novel exons
derived from the intergenic region. We detected nine ex-
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Figure 5. SMN circRNA production in human tissues. (A) MESDA depicting the splicing pattern of linear SMN pre-mRNA in different human tissues.
Band identities are given on the right side of the gel. ‘’ indicates SMN transcripts with skipped exon(s). ‘+6B’ indicates a full-length SMN transcript that
also contains Alu-derived exon 6B. Tissue type is given at the top of each lane. Abbreviations: Br, brain; Sc, spinal cord; Ht, heart; Sk, skeletal muscle; Sm,
smooth muscle; Lv, liver; Kd, kidney; Ln, lung; Ut, uterus; Ts, testis. (B) Ethidium bromide stained gels of divergent RT-PCR using human-tissue-derived
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Figure 6. Exons of mouse Smn are involved in formation of a wide variety of circRNAs. (A) Top panel: A schematic presentation of the mouse Smn locus.
Exons are depicted by colored shapes with red outlines, and introns are shown as lines/broken lines. Exon sizes are indicated by numbers in black below
exons and intron sizes are indicated by numbers in gray above introns. The location of a novel 5′ss within exon 8 is shown with a black arrow. Curved yellow
arrows represent backsplicing events, their thickness corresponds to the estimated prevalence of each event. Lower panels: An overview of the identified
circRNAs with their sizes given in nucleotides. The most abundant circRNA is boxed in red. (B–I) Ethidium bromide stained gels of divergent RT-PCR
products. The exon to which each divergent primer pair anneals is given at the top of each gel. Band identities marked on the right side of each gel were
determined by cloning and sequencing. Nomenclature of circRNA is the same as in Figure 2, with the exception that all circRNAs are labeled with ‘m’ to
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sites within exon 8 (Supplementary Figure S14). However,
appearance of these products could be an artefact of back-
ground amplification.
Interestingly, we also identified one circRNA,
mCI4(754)-5-6-I6(237) which incorporated exons 5 and 6,
as well as partial introns 4 and 6 immediately upstream and
downstream from them, respectively (Figure 6F). We did
not detect any canonical splice site for backsplicing that
likely generates this product. Analysis revealed deletion of
sequences between a common 7-nt motif, (CUGGUCU),
that was present in both introns 4 and 6 (Supplementary
Figure S17). It is likely that mCI4(754)-5-6-I6(237) is
generated from a lariat intermediate using the 5′ss of exon 4
and a branch point in intron 6. We speculate that a unique
structural context brings the common 7-nt motif in close
proximity, allowing RT slippage (Supplementary Figure
S17).
Depletion of DHX9 triggers perturbations of SMN pre-
mRNA splicing and circRNA generation
DHX9, a member of the DEAH-containing family of
RNA helicases, specifically disrupts IAR-associated-
double-stranded RNA structures (32). To find a potential
correlation between splicing/backsplicing of various
SMN exons and IAR-associated-double-stranded RNA
structures, we monitored levels of linear and circular
transcripts upon siRNA-mediated depletion of DHX9. In
parallel, we also monitored levels of linear and circular
transcripts upon siRNA-mediated depletion of DDX5
and DDX17. Of note, DDX5 and its paralog DDX17 are
highly conserved DEAD box helicase family members that
are known to modulate transcription, pre-mRNA splicing
and miRNA biogenesis through structural rearrangement
(66). We performed these experiments after confirming
by western blot that proteins remain depleted at 96 hours
post siRNA transfection. We used two different siRNAs
per gene to make sure that the results are not skewed by
any specific siRNA sequence. Indeed, we observed near
identical results with both siRNAs against all three of
the genes we examined. Depletion of DDX5 caused a
significant upregulation of DDX17 (Figure 7A, lanes 5 and
6). However, we did not capture a reciprocal upregulation
of DDX5 upon depletion of DDX17 (Figure 7A, lanes
7 and 8). Depletion of DHX9 had no effect on levels of
DDX5 or DDX17 or vice versa (Figure 7A). We employed
MESDA to capture the relative abundance of linear SMN
transcripts generated by alternative splicing (Figure 7B).
Depletion of DDX5 and DDX17 showed no appreciable
effect on alternative splicing of SMN exons (Figure 7B,
lanes 5–8). However, depletion of DHX9 showed an
enhanced skipping of exon 3 with or without skipping of
other exons (Figure 7B, lanes 3 and 4). The most unusual
splice variants were 3,4, 3–5, 3,4,7, 3–5,7, 5–7,
2B-5,7 and 2A-5,7 indicating that DHX9 depletion
caused a general perturbation of linear splicing of all
internal exons of SMN.
To monitor the levels of SMN transcripts in helicase-
depleted cells, we performed qPCR using various primer
combinations (Figure 7C). Since we prepared cDNAs us-
ing DNase-treated RNAs as template and oligo(dT)12–18
as primer, our approach allowed amplification of all
polyadenylated transcripts. Depletion of DHX9, DDX5
and DDX17 had no effect on levels of total SMN tran-
scripts (Figure 7C). Consistent with the results of MESDA
(Figure 7B), results of qPCR confirmed substantial increase
in the levels of 3–5 transcripts in samples with DHX9
depletion but not in samples with the depletion of either
DDX5 or DDX17 (Figure 7C). Interestingly, DHX9 deple-
tion caused an increase in the levels of transcripts contain-
ing novel intergenic exons of SMN (Figure 7C). These re-
sults are consistent with the recent finding that DHX9 de-
pletion causes readthrough downstream of the poly(A) sig-
nal (67).
For the assessment of SMN circRNAs impacted by de-
pletion ofDHX9,DDX5 andDDX17, we prepared cDNAs
using RNase R-treated RNAs as template and RT primers
annealing to exons 3 and 6. We then performed PCR em-
ploying divergent primer pairs annealing to each of these
exons.While we expected variations in the levels of some cir-
cRNAs due to sample-specific sensitivity to RNase R treat-
ment, we were able to capture significant changes in the ex-
pression of several circRNAs uponDHX9 depletion. Using
divergent primers located in exon 3, we observed upregula-
tion of C3-4 when DHX9 was knocked down (Figure 7D,
lanes 3 and 4). This finding is consistent with the enhanced
skipping of exons 3 and 4, since C3-4 could be generated
from the lariat intermediate harboring skipped exons 3 and
4. Compared to C3-4, levels of C2B-3-4 were substantially
downregulated upon depletion of DHX9 (Figure 7D, lanes
3 and 4). This result is anticipated based on the logic that the
5′ss of exon 4 competes with the 3′ss of exons 2B and 3 for
the generation of C2B-3-4 and C3-4, respectively. In agree-
mentwith the enhanced skipping of exons 5 and 6, depletion
of DHX9 produced increased expression of three type 3 cir-
cRNAs, C6-6B, C6-10 and C5-6 (Figure 7E, lanes 3 and 4).
Depletion of DHX9 also trigged abnormally high expres-
sion of circRNAs harboring intergenic exons, especially the
Grp2 circRNAs (Figure 7E, lanes 3 and 4). In order to de-
termine whether the increase in Grp2 circRNAs was due to
an increase in any specific events or whether it was a general
increase, we sequenced 10 clones from control and DHX9
knockdown samples. In control samples, the Grp2 popu-
lation was relatively evenly distributed between C6-6B-7-8
(four clones), C6-7-8A-9tr1 (four clones), and C6-7-8A-10
(two clones). In contrast, in DHX9 knockdown samples, 6
of the 10 clones were C6-7-8A-9tr1 and 1 was C6-7-8A-9,
for a total of seven clones using the 5′ss of exon 9/9tr1 and
the 3′ss of exon 6 for backsplicing.
Effect of transcription elongation inhibition on generation of
SMN circRNAs
DRB is one of the most widely used compounds to inhibit
transcription elongation as well as to study coupling be-
tween transcription elongation and splicing (68–70). De-
pending upon the context, DRB has been found to pro-
mote both inclusion and skipping of exons (68–70). To ex-
amine the effect of transcription elongation inhibition on
splicing of SMN exons, we treated HeLa cells with 80 M
DRB for four timepoints: 4, 8, 12 and 24 h. We then mon-
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Figure 7. Knockdown of DHX9 impacts specific circRNAs formed by SMN. (A) Left panel: Western blots indicating levels of DHX9, DDX5 andDDX17
with and without siRNA transfection. -tubulin, -actin and GAPDH are used as loading controls. Sample treatment is indicated at the top of the panel.
Antibody used is indicated at the right and nearby molecular weight markers are indicated at the left. Right panel: quantification of western blot results.
For each band, background signal was subtracted and then signal was normalized by -actin. Quantification and statistical analysis was performed on
two replicates using two independent siRNAs targeting each gene (n = 4). Error bars represent standard error of the mean (SEM). *P < 0.05, **P < 0.01
compared to untransfected and siRNA control samples. (B) MESDA depicting the splicing pattern of the linear SMN pre-mRNA. Treatment type is
indicated at the top of the gel. Band identities are marked on the right side of the gel. ‘’ indicates SMN transcripts with skipped exon(s). (C) Diagrammatic
representation of exon/intron organization and splicing of SMN1/SMN2. Exons are depicted as colored boxes, and introns are shown as lines/broken
lines. Transcriptional start site (TSS), polyA (pA) and location of primers used for qPCR are indicated. (D) Top panel: Ethidium bromide stained gel of
divergent RT-PCR using primers annealing to exon 3, which produces mostly type 1 circRNAs. Treatment type is indicated at the top of the gel. Band
identities are marked on the right side of the gel. Bottom panel: Quantification of the three most predominant bands from RT-PCR. Error bars represent
SEM. (E) Top panel: Ethidium bromide stained gel of divergent RT-PCR using primers annealing to exon 6, which produces mostly type 3 circRNAs.
Treatment type is indicated at the top of the gel. Band identities are marked on the right side of the gel. Bottom panel: Quantification of the four most
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MESDA. As expected, DRB treatment caused a noticeable
reduction in the full-length SMN transcripts (Supplemen-
tary Figure S18). Surprisingly, DRB treatment also caused
an increase in exon 3 skipping, suggesting a coupling be-
tween SMN transcription elongation rate and exon 3 splic-
ing (Supplementary Figure S18). For subsequent analyses,
we chose 8-hour duration ofDRB treatment, at which point
we observed ∼50% reduction in the full-length SMN tran-
scripts andmaximum skipping of exon 3 (Figure 8A and B).
Results of MESDA at 8-hour DRB treatment revealed two
prominent bands of near equal intensity corresponding to
exon 3 skipping. One of these bands (top band) harbored
exon 7, whereas, the other band (bottom band) lacked exon
7 (Figure 8A). We also detected faint bands correspond-
ing to co-skipping of exon 3 with other exons (Figure 8A).
Interestingly, while we observed an increase in the relative
abundance of 3,5, and 3,7 transcripts, we noticed a re-
duction in the levels of 5 and of 7 transcripts (Figure
8A).
We next analyzed the relative abundance of SMN circR-
NAs in HeLa cells treated with 80 MDRB for 8 h. In par-
ticular, we wanted to see if the levels of the exon 3-lacking
circRNAs (C2B-4 and C2A-2B-4) were elevated in DRB-
treated samples. We also expected reduction in the relative
abundance of C3-4 and C2A-2B-3-4 transcripts. However,
we observed no noticeable difference in the relative abun-
dance of any of the SMN circRNAs upon DRB treatment
(Figure 8C–E). These results suggested that the inhibition
of transcription elongation did not disproportionally im-
pact the splice site pairing for backsplicing. These findings
are consistent with a recent report supporting that the gen-
eration of circRNAs is mostly a posttranscriptional event
(71). We also employed an ISS-N1-targeting ASO (Anti-
N1) to capture the effect of the enhanced inclusion of exon
7 on levels of various SMN circRNAs. We observed no ap-
preciable change in the relative abundance of any SMN cir-
cRNAs upon ASO-mediated induction of exon 7 inclusion
in both HeLa and GM03813 cells (Supplementary Figure
S19). These results suggest that the splicing of exon 7 is not a
limiting factor for the generation of type 3 circRNAs, most
of which harbor exon 7.
Type 1 circRNAs cross-regulate their own expressions
We next examined the effect of depletion of C2B-3-4, one of
themost predominantly expressed circRNAs, on the expres-
sion of other type 1 circRNAs. We meticulously engineered
a RNase H compatible gapmer ASO, Jn4-2B, that annealed
to the exon 4-exon 2B junction (Figure 9A).
We then transfected HeLa cells with Jn4-2B to deplete
C2B-3-4. For circRNA analysis, we used RNase R-treated
total RNA as template followed by RT-PCR using diver-
gent primers annealing to exon 3. As expected, Jn4-2B gap-
mer almost completely depleted C2B-3-4. A control gapmer
ASO with scrambled sequence had no appreciable effect
on the relative expression of C2B-3-4. Depletion of C2B-
3-4 upregulated C3-4 and C2A-2B-3-4, although the ratio
between C3-4 and C2A-2B-3-4 appeared to be unchanged
(Figure 9B, lanes 3 and 4). We performed complementary
experiments to assess the effect of the gapmer-assisted de-
pletion of either C3-4 or C2A-2B-3-4 on other type 1 circR-
NAs. While depletion of C3-4 disproportionately upregu-
lated C2B-3-4 (Figure 9B, lanes 3 and 5), depletion of C2A-
2B-3-4 upregulated both C3-4 and C2B-3-4, although the
ratio between C3-4 and C2B-3-4 remained unchanged (Fig-
ure 9B, lanes 3 and 6). Overall, our results suggest that the
absence of a given type 1 circRNA has a stabilizing effect
on other type 1 circRNAs. Alternatively, it is also possible
that the presence of a given type 1 circRNA interferes with
the generation of other type 1 circRNAs. We performed
MESDA to examine if the depletion of one of the abun-
dantly expressed type 1 circRNAs has any effect on the rel-
ative abundance of the linear SMN splice isoforms. Results
ofMESDA showed no appreciable effect of the depletion of
C2B-3-4, C3-4 and C2A-2B-3-4 on any of the linear splice
isoforms of SMN (Figure 9C). We observed no significant
effect of the depletion of any of the above expressed type 1
circRNAs on the overall levels of the SMN transcripts (Fig-
ure 9D).
DISCUSSION
The diversity and abundance of circRNAs present within
the human transcriptome is currently beyond the realms of
accurate prediction due to the non-colinear nature of circR-
NAs coupled with the unpredictable usage of novel splice
sites to generate circRNAs. Thus, a tailored approach pro-
vides a powerful alternative to uncover the entire spectrum
of gene-specific circRNAs. Employing such an approach,
here we report the surprising diversity of exon-containing
circRNAs generated by human SMN genes that code for
SMN, an essential protein implicated in several housekeep-
ing functions. While the coding sequence of SMN is highly
conserved in mammals, frequent insertions of Alu elements
in primates have introduced substantial differences in the
intronic, promoter and intergenic regions of human SMN
genes (Figure 1). Considering that IARs are strong drivers
of circRNAgeneration (19,29–31),SMN offers an ideal sys-
tem to test the higher limit of circRNAs generated by a sin-
gle gene. We analyzed SMN circRNAs after treatment of
total RNA with RNase R, which selectively removes lin-
ear transcripts. To maximize the chances of identification
of most exon-containing circRNAs, we generated cDNA li-
braries using RT primers annealing to each internal exon
followed by PCR using divergent primers annealing to their
respective exons. To further enhance the chances of cap-
turing the full spectrum of SMN circRNAs, we performed
these experiments in multiple cell types and postmortem
human tissues. We conclusively validated 53 SMN circR-
NAs belonging to four broad types based on the identities
of the included exon(s). Among validated circRNAs, 16, 12,
23 and 2 belonged to types 1, 2, 3 and 4 categories, respec-
tively (Figures 2 and 3). In addition to confirming the pres-
ence of all known exons in one or more circRNAs of SMN,
our results uncovered several novel exons that were incorpo-
rated intoSMN circRNAs.We also validated the expression
of most SMN circRNAs in RNA samples from ten post-
mortem human tissues, including brain, spinal cord, heart,
liver, lung, kidney, testis, uterus, and smooth and skeletal
muscles (Figure 5).
The exceptional diversity of SMN circRNAs was fa-
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Figure 8. DRB treatment for 8 h impacts only linear transcripts of SMN. (A) Left panel: MESDA depicting splicing of the linear SMN pre-mRNA with
and without DRB treatment. Treatment type is indicated at the top of the gel. Each treatment was performed in triplicate. Band identities are marked on
the right side of the gel. ‘’ indicates SMN transcripts with skipped exon(s). Right panel: quantification of relative band intensities. (B) Expression levels of
total SMN transcripts relative to the mean of the untreated samples. Error bars represent SEM. **P < 0.01 compared to untreated samples. The location
of primers used for qPCR is indicated. (C) Ethidium bromide stained gel of divergent RT-PCR using primers annealing to exon 3, which produces mostly
type 1 circRNAs. Treatment type is indicated at the top of the gel. Band identities are marked on the right side of the gel. (D) Ethidium bromide stained
gel of divergent RT-PCR using primers annealing to exon 4, which produces mostly type 1 circRNAs. Labeling is the same as in (C). (E) Ethidium bromide
stained gel of divergent RT-PCR using primers annealing to exon 6, which produces mostly type 3 circRNAs. Labeling is the same as in (C).
(GU/AG) splice sites of various exons. Our results sug-
gested competition between neighboring and distant splice
sites for the incorporation into circRNAs. Consistently, we
identified circRNAs harboring as few as one exon and
as many as six exons. C2A-2B-3-4, C2B-3-4 and C3-4
were the most abundant circRNAs detectable by RPA, an
amplification-free approach (Supplementary Figure S12).
The 5′ and the 3′ss used to produce C3-4 and C2A-2B-3-
4 are separated by 413- and 4031-nt, respectively, suggest-
ing that the distance between splice sites used for backsplic-
ing did not play a significant role in the generation of the
most abundant circRNAs. Supporting this argument, RNA
structure and not sequence has been implicated as one of the
major drivers for backsplicing (7). Generation of C2B-3-4
is expected to be facilitated by bringing the 3′ss of exon 2B
closer to the 5′ss of exon 4 through an extensive complemen-
tarity between intron 2A and exon 4 (Supplementary Fig-
ure S6). Similarly, formation of C2A-2B-3-4 is likely aided
by bringing the 3′ss of exon 2A closer to the 5′ss of exon
4 through an extensive complementarity between intron 1
and exon 4 (Supplementary Figure S7). With significance
to the generation of C3-4, the predicted secondary struc-
ture encompasses extensive complementarity between in-
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Figure 9. Knockdown of specific circRNAs using gapmers. (A) Diagrammatic representation of circRNA degradation caused by gapmers. Inset on top
left shows design of a gapmer. Gapmer ASOs anneal to their respective targets and trigger degradation by an RNase H-mediated process. (B) Ethidium
bromide stained gel of divergent RT-PCR using primers annealing to exon 3. Treatment/transfection type is indicated above each lane. Band identities
are marked on the right side of the gel. Right panel: quantification of relative band intensities. (C) MESDA depicting the splicing pattern of linear SMN
pre-mRNA. Band identities are marked on the right side of the gel. ‘’ indicates SMN transcripts with skipped exon(s). (D) Expression levels of total SMN
transcripts in different treatment. Expression levels are expressed relative to the mean of the untransfected (Untr) samples. Error bars represent SEM. The
locations of primers used for qPCR are indicated by arrows. Abbreviations: Jn, Junction; Lipo, Lipofectamine 2000.
transcription coupled splicing regulation (37), secondary
structures may affect the outcome of backsplicing through
pausing of the pol II during transcription elongation (38).
However, there is also evidence to support that the genera-
tion of circRNAs is mostly a posttranscriptional event (71).
In agreement with this hypothesis, inhibition of transcrip-
tion elongation byDRBdid not alter the relative abundance
of SMN circRNAs (Figure 8).
We unexpectedly identified four circRNAs encompassing
three novel cryptic exons derived from intron 1 (Supplemen-
tary Figure S2). Three of these circRNAs,CI1(NE2-79)-2A,
CI1(NE1-98)-2A and CI1(NE3-33)-2A, were formed using
the 5′ss of exon 2A, the first internal exon. These results un-
derscored the mutually competing nature of dynamic struc-
tures formed by IARs, allowing pairing of a single 5′ss with
different cryptic 3′ss within intron 1. Formation of these
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5′ss of exon 2A available for pairing with the upstream 3′ss.
The most probable among these events is C2B-3-4 genera-
tion, which cleaves and releases the transcript upstream of
intron 2A. Interestingly, one of the cryptic exons, I1(NE3-
33), located towards the 3′-end of intron 1, was incorpo-
rated into two different circRNAs, CI1(NE3-33)-2A and
CI1(NE3-33)-2B-3-4. Formation of CI1(NE3-33)-2A-2B-
3-4 suggested that the backsplicing of a cryptic exon within
intron 1 is not limited to the 5′ss of the first internal exon.
Our results also confirmed that exon 4 is the farthest exon
to be backspliced with one of the cryptic exons within in-
tron 1. We observed two type 1 circRNAs, C1tr1-2A and
C1tr1-2A-2B, which used a novel 3′ss located close to the
translation start site within the first exon (Figure 2, Supple-
mentary Figure S9). Formation of C1tr1-2A-2B is possibly
enabled by delayed removal of intron 2B in transcripts that
have already undergone removal of introns 1 and 2A. Also,
production of C1tr1-2A-2B is likely facilitated by C3-4 gen-
eration, which results in cleavage and release of the tran-
script upstream of intron 2B. In general, it is possible that
the biogenesis of a vast majority of type 1 circRNAs is en-
hanced by the generation of type 3 circRNAs and vice versa.
Such a mode of regulation of circRNA formation would be
consistent with an efficient cellular machinery that is geared
to produce multiple products from a single precursor RNA.
Among the most surprising findings reported in this
study is the discovery of four intergenic exons, namely exons
9, 10, 11 and 12, located downstream of exon 8 (Figures 1
and 3, Supplementary Figure S3). Out of four intergenic ex-
ons, exon 9 is derived from an Alu element. Our results con-
firmed incorporation of each of these intergenic exons into
both linear and circular transcripts. However, we did not
capture any linear or circular transcript containing all four
intergenic exons (Figures 3 and 4). Of note, since we could
not validate the presence circRNAs harboring intergenic ex-
ons by RPA, we infer that they are expressed at very low lev-
els under normal conditions (Supplementary Figure S12).
Another surprising finding was the frequent incorporation
of exon 8A into both circular and linear transcripts due to
activation of a cryptic 5′ss at the 142nd position of exon 8
(Figures 3 and 4). We also identified extended versions of
exon 8A, generated by less frequent activation of yet other
cryptic sites at the 162nd and the 167th positions of exon 8.
In addition, we observed several rare circRNAs harboring
truncated sequences of exon 8. Generation of most of these
rare circRNAs were enabled by employment of the highly
unusual 5′ss throughout exon 8 (Supplementary Figure S9).
While usage of such splice sites has been recently reported
(72), it is also possible that the actual splice junction se-
quences are lost for some of these rare circRNAs due to slip-
page by reverse transcriptase. Of note, slippage by reverse
transcriptase causes deletion of sequences between two near
identical motifs (73). In most cases where we observed us-
age of unusual splice sites, we identified duplicate sequences
(not shown). Future studies employing slippage-proof re-
verse transcriptases would address discrepancies with re-
spect to the usage of the non-canonical splice sites.
Lariat intermediates harboring skipped exons enhance
the chances of circRNA formation due to elimination of a
large number of competing splice sites present within the
linear transcript. Generation of circRNAs via lariat inter-
mediate could be particularly feasible for exons with weak
splice sites. The 5′ss of the 201-nt-long exon 3 is one such
example. This site was used to produce a single, poorly de-
tectable circRNA, C3. Considering exon 3 undergoes alter-
native splicing, it is likely that C3 is generated from the lariat
intermediate harboring skipped exon 3. Similar to exon 3,
exon 5 is also an alternatively spliced exon. However, this
96-nt-long exon was the only internal exon for which the
5′ss was not used for backsplicing. We hypothesize that it is
due to the small size of exon 5, when itmay not be feasible to
generate a circRNA from a lariat intermediate.We captured
two circRNAs, C6B-7 and C5-6-7, that used the 5′ss of yet
another alternatively spliced SMN exon, exon 7. It is likely
that C6B-7 is generated from lariat intermediate harboring
skipped exons 6B and 7. We have recently shown that low
levels of a transcript lacking exons 3, 4, 5, 6, 7 is generated
in all tissues (74). Therefore, it is also possible that C5-6-7
is produced from a lariat intermediate harboring skipped
exons 3, 4, 5, 6, 7.
For an assessment of whether human SMN circRNAs
are evolutionarily conserved, we examined mouse Smn cir-
cRNAs expressed in the motor-neuron-like NSC-34 cells.
Compared to human SMN, mouse Smn produces a lesser
variety of circRNAs (Figure 6). This is expected due to the
low SINE content of the mouse Smn and a lack of tran-
scription elongation into the intergenic region. Similar to
human SMN, each internal mouse Smn exon is present at
least in one type of circRNA.Except for the identification of
the novel Smn exon 6B, our results did not reveal inclusion
of any cryptic exons into Smn circRNA. While mouse Smn
exon 6B shares no homology with human SMN exon 6B, we
confirmed that similar to human exon 6B, mouse exon 6B is
incorporated in both circular and linear transcripts (Figure
6, Supplementary Figure S16). Although nature and abun-
dance of most mouse Smn circRNAs were quite distinct
from those expressed by human SMN, we observed several
circRNAs that were expressed by both mouse and human
genes, suggesting common regulatory mechanisms for the
generation of these circRNAs. Consistently, the precursor
of mC2A-2B-3-4, the most predominantly expressed Smn
circRNA, shares several structural features with those of the
precursor of human C2A-2B-3-4 (Supplementary Figures
S7 and S15). In particular, in both there is an extensive base
pairing between intron 1 and exon 4. Mouse and human ex-
ons 8, which encompass the 3′-end processing site including
polyadenylation and cleavage motifs, share poor homology.
However, mouse Smn just like human SMN generates cir-
cRNAs employing cryptic splice sites within exon 8. It is
likely that delayed cleavage and polyadenylation promotes
circRNA production through activation of these random
cryptic splice sites within exon 8 (Supplementary Figures
S9 and S14). Supporting this argument, a recent study sug-
gests that inhibition of transcription termination via deple-
tion of cleavage and polyadenylation machinery enhances
circRNA production (75).
To gain mechanistic insight into the generation of circR-
NAs we depleted three RNA helicases, DHX9, DDX5 and
DDX17. While DHX9 is known to specifically disrupt sec-
ondary structures associated with IARs (32), DDX5 and
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tures (76). Our results of MESDA revealed a significant ef-
fect of depletion of DHX9 on splicing of various SMN ex-
ons. In particular, we observed skipping of many exons in
different combinations. These results represent the first ex-
ample of the effect of an Alu-associated helicase on regula-
tion of SMN splicing. As expected, enhancement in the for-
mation of secondary structures associated with IARs due to
DHX9 depletion caused upregulation of a select group of
circRNAs, including C3-4, C6, C5-6, C6-6B and C6-7-8A-
9. Based on the pattern of skipped exons, we infer that the
lariat intermediates harboring exons are the likely source
of the increase in circRNA production upon DHX9 deple-
tion. Interestingly, DHX9, also known as RNA helicase A
(RHA), interacts with SMN and SMA-causing mutations
of SMN disrupt the DHX9-SMN interaction (77). In addi-
tion, recent reports implicate the role of SMN and DHX9
in transcription termination andR-loop resolution (78–80).
It would be interesting to see if the low SMN levels affect-
ing R-loop resolution also impact generation of specific cir-
cRNAs of SMN. In addition to the aberrantly high expres-
sion of SMN circRNAs, depletion of DHX9 caused more
than 5-fold increase in the readthrough of the polyadeny-
lation site within exon 8 (Figure 7C). It remains to be seen
if the enhanced production of the readthrough transcripts
of SMN has any physiological significance. Unlike the case
with DHX9, we did not observe any significant effect of de-
pletion of DDX5 and DDX17 on linear or circular tran-
scripts of SMN. This is likely due to the presence of other
DEAD-box helicases with redundant functions.
Depletion experiments supported cross-regulation of ex-
pression and/or levels of various type 1 circRNAs. Exon 3
independently folds into rigid secondary structure due to
high sequence complementarity within this exon (Supple-
mentary Figures S5–S7). The independent folding of exon
3 is fully conserved in pre-mRNAs that generate C2B-3-4,
C3-4 and C2A-2B-3-4 (Supplementary Figures S5–S7). It is
likely that exon 3 present within any of the abundantly ex-
pressed type 1 circRNAs disrupts the intramolecular struc-
ture of exon 3 of SMN pre-mRNA through formation of
the intermolecular structures between complementary se-
quences within exon 3. This could be one of the possible
mechanisms by which levels of various type 1 circRNAs are
cross-regulated. It is also likely that the interacting proteins
stabilize type 1 circRNAs. In this scenario, proteins released
upon depletion of one type 1 circRNAare likely to associate
with other type 1 circRNAs and stabilize them.
Thus far, most functions of the SMN genes have been
associated with the SMN protein and its isoforms (39,81).
Two recent reports suggest a role for non-coding antisense
transcripts generated by SMN (82,83). A vast repertoire
of circRNAs generated by Alu-rich SMN reported in this
study opens up a new frontier that has not yet been ex-
plored. Despite low abundance of individual circRNAs, the
sum of all circRNAs is likely to account for a sizeable frac-
tion of the total transcripts generated by SMN. Since the
approach adopted in this study was tailored to identify
only exon-containing circRNAs, the number and expres-
sion levels of intron-only-containing circRNAs of SMN re-
mains to be explored. Furthermore, considering circRNAs
sponge miRNAs and proteins as well as regulate transcrip-
tion (4,5,7), our findings are likely to expand the role of
SMN in global regulation of translation, transcription and
macromolecular trafficking. Based on recent reports sup-
porting the generation of short peptides by circRNAs (6),
SMN has a potential to produce a vast array of peptides
longer than 50 amino acids through translation of its di-
verse circRNAs. Exons 4 and 6 contain translation initia-
tion codons and all internals exons except exons 6B and
7 lack translation termination codons. Future studies will
determine if the initiation of translation within exon 4 or
exon 6 generates large protein(s) from one or more of the
abundant SMN circRNAs encompassing these exons. An
overwhelming majority of type 3 circRNAs harbored exon
7. However, we did not find a direct correlation between
an enhanced exon 7 inclusion and the relative abundance
of type 3 circRNAs (Supplementary Figure S19). It likely
that the type 3 circRNAs are generated mostly after exon
7 inclusion. Many SMA patients have deletions of SMN1
exon 7 and/or exon 8 as well as mutations in splice sites
that facilitates exon 7 skipping (39,53,84). These deletions
and/or mutations will affect the generation of type 3 circR-
NAs, including the most predominant C6-7-8A. Further in-
vestigations will establish if the loss of C6-7-8A contributes
towards SMA pathogenesis. SMN is an essential gene for
survival of all organisms belonging to the animal kingdom.
Notably, a large fraction of circRNAs generated by SMN
are specific to primates. Hence, any role linked to these cir-
cRNAs will underscore their evolutionary significance as
well as improve our understanding of SMN gene function
in primates.
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